"Jan. 23, 2013 -- Worrying about what may trigger a migraine attack adds to the discomfort of many people with migraines. But according to a new study from Denmark, much of that worry may be unfounded.
The researchers studied the effect of l"...
Signs And Symptoms
Patients and volunteers receiving single oral doses of 100 to 150 mg of almotriptan did not experience significant adverse events. Six additional normal volunteers received single oral doses of 200 mg without serious adverse events. During clinical trials with AXERT® (almotriptan malate), one patient ingested 62.5 mg in a 5-hour period and another patient ingested 100 mg in a 38-hour period. Neither patient experienced adverse reactions.
There is no specific antidote to AXERT® . In cases of severe intoxication, intensive care procedures are recommended, including establishing and maintaining a patent airway, ensuring adequate oxygenation and ventilation, and monitoring and support of the cardiovascular system.
Clinical and electrocardiographic monitoring should be continued for at least 20 hours even if clinical symptoms are not observed.
Ischemic Or Vasospastic Coronary Artery Disease, Or Other Significant Underlying Cardiovascular Disease
Do not use AXERT® (almotriptan malate) in patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), or in patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal's variant angina, or other significant underlying cardiovascular disease [see WARNINGS AND PRECAUTIONS].
Peripheral Vascular Disease
Because AXERT® may increase blood pressure, do not use AXERT® in patients with uncontrolled hypertension [see WARNINGS AND PRECAUTIONS].
Ergotamine-Containing And Ergot-Type Medications
Concomitant Use With 5-HT1 Agonists (e.g., Triptans)
AXERT® and other 5-HT1 agonists (e.g., triptans) should not be administered within 24 hours of each other [see WARNINGS AND PRECAUTIONS].
Hemiplegic Or Basilar Migraine
AXERT® is contraindicated in patients with known hypersensitivity to almotriptan or any of its inactive ingredients.
Last reviewed on RxList: 8/21/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Axert Information
Axert - User Reviews
Axert User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find the secrets to longer life.